Native tissue provides lasting support and strength through 24 months1

Not only does SERI® Surgical Scaffold offer immediate soft tissue support for your patients, it also facilitates the generation of strong and supportive tissue.1,2

As SERI® Surgical Scaffold is bioresorbed, the support and strength gradually shift from SERI® Surgical Scaffold to the newly ingrown tissue over 24 months.1

At 24 months, native tissue was stronger than ovine fascia sampled and evaluated from 2 locations (rectus abdominis/internal oblique)1

Delivers continuous soft tissue support through gradual bioreplacement1,2

At 24 months, native tissue was stronger than ovine fascia sampled and evaluated from 2 locations (rectus abdominis/internal oblique)1

Delivers continuous soft tissue support through gradual bioreplacement1,2

  • Nearly 2x average strength of ovine fascia1:
    Newly generated tissue demonstrated nearly twice the average strength of ovine fascia at 24 months
  • Supports majority of load-bearing responsibility1:
    Newly generated tissue provided the majority of load-bearing strength by 6 months

Methodology: In an ovine subcutaneous thoracic wall implant study designed to measure the strength and thickness of SERI® Surgical Scaffold and newly generated native tissue at up to 24 months after implantation of SERI®.1
Note: Similar studies in humans have not been performed.

Bioreplaced
Over Time1,*

Learn More

Favorable
Biocompatibility1,

Learn How Our Silk is Different

*Methodology: In an ovine subcutaneous thoracic wall implant study designed to measure the strength and thickness of SERI® Surgical Scaffold and newly generated native tissue at up to 24 months after implantation of SERI®.1
Note: Similar studies in humans have not been performed.

Methodology: In a study using SERI® Surgical Scaffold in a rat model of abdominal wall defect.1
Note: Similar studies in humans have not been performed.


Indications for Use
SERI® Surgical Scaffold is indicated for use as a transitory scaffold for soft tissue support and repair to reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction.

Important Safety Information
Contraindications

  • Patients with a known allergy to silk
  • Contraindicated for direct contact with bowel or viscera where formation of adhesions may occur

Warnings

  • SERI® Surgical Scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling
  • Caution should be used when implanting SERI® Surgical Scaffold in pregnant women. The use of a device that can impede tissue expansion may be hazardous during pregnancy

Adverse Reactions
Adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.

Important: Before using SERI® Surgical Scaffold, read the Instructions for Use which accompany the product for full safety information. This can be found here.

Caution: Rx only.

Instructions for Use   |   Sofregen Medical Privacy Statement   |  

Terms of Use   |   SofregenMedical.com   |   Contact Sofregen Medical   |  

Site Map   |   References

©Sofregen Medical Inc., One Kendall Square, Cambridge, MA 02139 ® marks owned by Sofregen Medical Ireland LTD
  APC12MN15   152333